Literature DB >> 21359594

Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil?

Michael Tachezy1, Maximilian Bockhorn, Florian Gebauer, Yogesh K Vashist, Jussuf Thomas Kaifi, Jakob Robert Izbicki.   

Abstract

OBJECTIVE: As technical expertise increases, the indication for pancreatic resection for advanced pancreatic cancer has been expanded over the last years. Recently, several groups reported their series of unintentionally incomplete tumor resections and reported a potential survival benefit for patients after incomplete resection when compared with palliative bypass surgery. We investigated in a retrospective analysis whether even tumor resection that was intended to be incomplete might provide a better outcome than conventional palliative procedures.
METHODS: Twenty-two patients with a locally non-resectable or disseminated adenocarcinoma of the pancreas underwent a palliative intentionally incomplete resection. Outcome after resection was compared with that of 46 patients matched for age, sex, and histopathological tumor type who underwent a palliative bypass operation.
RESULTS: Overall surgical morbidity was significantly higher in the resection group (59%) compared with the bypass group (33%, p < 0.05), resulting in a higher relaparotomy rate and a significantly longer postoperative hospital stay (p < 0.001). Surgery-related mortality was significantly higher in the resection group (p < 0.05). Overall survival showed no statistically significant difference between the two groups.
CONCLUSIONS: Because of the higher surgery-related morbidity and mortality and lack of survival benefit in cases of advanced adenocarcinoma of the pancreas, intentionally incomplete palliative resection is not advisable.

Entities:  

Mesh:

Year:  2011        PMID: 21359594     DOI: 10.1007/s11605-011-1469-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  18 in total

1.  Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Authors:  Douglas B Evans; Michael B Farnell; Keith D Lillemoe; Charles Vollmer; Steven M Strasberg; Richard D Schulick
Journal:  Ann Surg Oncol       Date:  2009-04-23       Impact factor: 5.344

2.  Are there indications for palliative resection in pancreatic cancer?

Authors:  D J Gouma; E J Nieveen van Dijkum; R C van Geenen; T M van Gulik; H Obertop
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

Review 3.  Advances in the surgical management of pancreatic cancer.

Authors:  K Spanknebel; K C Conlon
Journal:  Cancer J       Date:  2001 Jul-Aug       Impact factor: 3.360

4.  Microscopically incomplete resection offers acceptable palliation in pancreatic cancer.

Authors:  Koert Kuhlmann; Steve de Castro; Tjarda van Heek; Olivier Busch; Thomas van Gulik; Hugo Obertop; Dirk Gouma
Journal:  Surgery       Date:  2006-02       Impact factor: 3.982

5.  Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma.

Authors:  E J M Nieveen van Dijkum; K F D Kuhlmann; C B Terwee; H Obertop; J C J M de Haes; D J Gouma
Journal:  Br J Surg       Date:  2005-04       Impact factor: 6.939

6.  Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy.

Authors:  Markus W Büchler; Markus Wagner; Bruno M Schmied; Waldemar Uhl; Helmut Friess; Kaspar Z'graggen
Journal:  Arch Surg       Date:  2003-12

7.  Crossing the Rubicon: when pancreatic resection with curative intent ends in an R2 status. Impact of "desmoplastic pseudo-pancreatitis" and anatomical site of irresectability.

Authors:  Maximilian Bockhorn; Guellue Cataldegirmen; Asad Kutup; Andreas Marx; Christoph Burdelski; Jogesh K Vashist; Oliver Mann; Lena Liebl; Alexandra König; Jakob R Izbicki; Emre F Yekebas
Journal:  Ann Surg Oncol       Date:  2009-02-19       Impact factor: 5.344

8.  Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections.

Authors:  Emre F Yekebas; Lars Wolfram; Guellue Cataldegirmen; Christian R Habermann; Dean Bogoevski; Alexandra M Koenig; Jussuf Kaifi; Paulus G Schurr; Michael Bubenheim; Claus Nolte-Ernsting; Gerhard Adam; Jakob R Izbicki
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

9.  R2 resection in pancreatic cancer--does it make sense?

Authors:  Jörg Köninger; Moritz N Wente; Beat P Müller-Stich; Francesco F di Mola; Carsten N Gutt; Ulf Hinz; Michael W Müller; Helmut Friess; Markus W Büchler
Journal:  Langenbecks Arch Surg       Date:  2008-02-29       Impact factor: 3.445

10.  Standards for pancreatic resection in the 1990s.

Authors:  C Fernández-del Castillo; D W Rattner; A L Warshaw
Journal:  Arch Surg       Date:  1995-03
View more
  4 in total

Review 1.  Advanced-stage pancreatic cancer: therapy options.

Authors:  Jens Werner; Stephanie E Combs; Christoph Springfeld; Werner Hartwig; Thilo Hackert; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2013-04-30       Impact factor: 66.675

Review 2.  Pancreatic cancer and liver metastases: state of the art.

Authors:  Eugen Bellon; Florian Gebauer; Michael Tachezy; Jakob R Izbicki; Maximilian Bockhorn
Journal:  Updates Surg       Date:  2016-11-10

Review 3.  Surgical resection strategies for locally advanced pancreatic cancer.

Authors:  Alexander Gluth; Jens Werner; Werner Hartwig
Journal:  Langenbecks Arch Surg       Date:  2015-06-27       Impact factor: 3.445

4.  Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.

Authors:  Younghwan Kim; Song Cheol Kim; Ki Byoung Song; Jayoun Kim; Dae Ryong Kang; Jae Hoon Lee; Kwang-Min Park; Young-Joo Lee
Journal:  HPB (Oxford)       Date:  2016-02-08       Impact factor: 3.647

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.